Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

A specific mutation in the TRPV3 gene causes hair follicle cells to develop improperly, leading to hair loss.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

A parasite molecule can speed up skin healing and reduce scarring.

Three genes linked to the development of trichilemmal cysts were found.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Blocking mTORC1 activity could increase hair pigmentation and potentially reverse greying.

The study created a mouse model to better understand hair follicle stem cells' role in hair growth and repair.

Different γδ T cell types have unique roles in causing alopecia areata.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Activated β-catenin affects hair growth and skin thickness, and changes are reversible.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Dermatologists should consider congenital syndromes like TRPS in young adults with early hair loss.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Mice without the vitamin D receptor are more prone to UV-induced skin tumors.

ROS may affect hair loss related to hormones.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

TPO antibodies can help identify hypothyroid patients who still have symptoms despite normal TSH levels.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.